ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #5,463Hybrid

Clinica Chimica Acta

Acronym:ccacta
•
Abbreviation (ISO):CLIN. CHIM. ACTA
•
Identifier (ISSN):0009-8981(Print)/1873-3492(Online)
•
Publisher:Elsevier
Clarivate IF (2026)
4.1↑ +1.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Clinica Chimica Acta

WoS Q1
14692.9320182.7320192.6220203.7920216.312022520233.220242.920254.12026
Annual Impact Factor Metric
Current (2026):4.1
Scopus SJR & RankScopus Q1
0.935
#5,463

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
182

182 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate6.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
349articles/year
21.31% Gold OA•93.94% Original Research

Aims & Scope

The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells. The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.

Topics Covered (Recognized by AI)
Biology85.2%Medicine83.2%Chemistry81.8%Internal medicine71.8%Biochemistry69.3%Genetics53.5%Endocrinology51.2%Organic chemistry43.7%Physics41.3%Chromatography32.3%Nuclear magnetic resonance26.4%Pathology26.1%Immunology25.8%Enzyme25.1%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

MEDICAL LABORATORY TECHNOLOGY

Q1
Rank8/33
IndexSCIE
JCISCIE2026

MEDICAL LABORATORY TECHNOLOGY

Q1
Rank8/33
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.1
Articles / Year442
Total Citations193
2025
IF2.9
Articles / Year584
Total Citations1,825
2024
IF3.2
Articles / Year2,214
Total Citations3,825
2023
IF5
Articles / Year376
Total Citations4,020
2022
IF6.314
Articles / Year1,282
Total Citations4,395

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,463Scopus Q1SCImago Profile
Scopus Coverage:1956-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
0.935

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.13

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,333 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations4,017
3-Year Documents1,028
Citable Documents1,003

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
BiochemistryQ2
Biochemistry (medical)Q2
Clinical BiochemistryQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 6.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区MEDICAL LABORATORY TECHNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinica Chimica Acta (acronym: ccacta, abbr: CLIN. CHIM. ACTA, ISSN: 0009-8981) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in Netherlands since 1956. The periodical holds a Journal Impact Factor (JIF) of 4.10, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 0.935 (Q1), an H-index of 182.

The journal enforces rigorous peer evaluation with an average review speed of 5.2周, a publication frequency of Monthly, an annual output of approximately 349 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,333 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier
Publication Language
English
Frequency
Monthly
Founding Year
1956
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: ce181ba3-dc9a-4779-a247-f439cda62b24
Database Updated: 2026-10-01